STEM CELL ASSURANCE, INC. ANNOUNCES CHANGE OF NAME TO BIORESTORATIVE THERAPIES, INC.
Aug 17, 2011
OTC Disclosure News Service
Jupiter, FL –
STEM CELL ASSURANCE, INC. ANNOUNCES CHANGE OF NAME TObiorestorative therapies, inc.
New Web Site Address: www.biorestorative .com
JUPITER, FL,August 17, 2011 – Stem Cell Assurance, Inc. (SCLZ.PK) (the “Company”) today announcedthat its name has been changed to “BioRestorativeTherapies, Inc.” The Company’s new website address is: www.biorestorative.com.
BioRestorative Therapies has been advised by the Financial Industry Regulatory Authority(FINRA) that the trading symbol for the Company’s common stock will change from“SCLZ” to “BRTX” thirty days following FINRA’s announcement of the Company’ssymbol change.
Mark Weinreb, the Company’s Chairman andChief Executive Officer, said, “Our new name more accurately represents ourbusiness direction focusing on cellular-based therapies and signals thebeginning of our branding of the Company and the initiatives we are pursuing.”
About BioRestorativeTherapies, Inc.
BioRestorative Therapies, Inc.’s goal is to become a medical center ofexcellence using cell and tissue protocols, primarily involving a patient’s own(autologous) adult stem cells (non-embryonic),allowing patients to undergo cellular-based treatments. In June 2011, the Company launched a platform technology that involves the use of a brown fat cell-based therapeutic/aesthetic program, known as the ThermoStem Program. The ThermoStem Program will focus ontreatments for obesity, weight loss, diabetes, hypertension, other metabolicdisorders and cardiac deficiencies and will involve the study of stem cells,several genes, proteins and/or mechanisms that are related to these diseasesand disorders. As more and morecellular therapies become standard of care, the Company believes its strengthwill be its focus on the unity of medical and scientific explanations forclinical procedures and outcomes for future personal medical applications. The Company also plans to offer and sellfacial creams and products under the Stem Pearls™ brand.
This press release contains “forward-lookingstatements” within the meaning of Section 27A of the Securities Act of 1933, asamended, and Section 21E of the Securities Exchange Act of 1934, as amended,and such forward-looking statements are made pursuant to the safe harborprovisions of the Private Securities Litigation Reform Act of 1995. You arecautioned that such statements are subject to a multitude of risks anduncertainties that could cause future circumstances, events or results todiffer materially from those projected in the forward-looking statements as aresult of various factors and other risks, including those set forth in theCompany’s Form 10, as amended, filed with the Securities and Exchange Commission.You should consider these factors in evaluating the forward-looking statementsincluded herein, and not place undue reliance on such statements. Theforward-looking statements in this release are made as of the date hereof andthe Company undertakes no obligation to update such statements.
Tel: (561) 904-6070
Fax: (561) 429-5684
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.